Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad
J Cyst Fibros. 2025 Nov 27:S1569-1993(25)02528-7. doi: 10.1016/j.jcf.2025.11.013. Online ahead of print. ABSTRACT There are a paucity of data regarding the pharmacokinetics (PK) of elexacaftor …